Follow
Kai Xu
Kai Xu
UTHealth Houston
Verified email at nih.gov - Homepage
Title
Cited by
Cited by
Year
Unmutated and mutated chronic lymphocytic leukemias derive from self-reactive B cell precursors despite expressing different antibody reactivity
M Hervé, K Xu, YS Ng, H Wardemann, E Albesiano, BT Messmer, ...
The Journal of clinical investigation 115 (6), 1636-1643, 2005
4252005
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody
R Kong, K Xu, T Zhou, P Acharya, T Lemmin, K Liu, G Ozorowski, C Soto, ...
Science 352 (6287), 828-833, 2016
3272016
Architecture of Eph receptor clusters
JP Himanen, L Yermekbayeva, PW Janes, JR Walker, K Xu, L Atapattu, ...
Proceedings of the National Academy of Sciences 107 (24), 10860-10865, 2010
3122010
Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1
K Xu, P Acharya, R Kong, C Cheng, GY Chuang, K Liu, MK Louder, ...
Nature medicine 24 (6), 857-867, 2018
2752018
Host cell recognition by the henipaviruses: crystal structures of the Nipah G attachment glycoprotein and its complex with ephrin-B3
K Xu, KR Rajashankar, YP Chan, JP Himanen, CC Broder, DB Nikolov
Proceedings of the National Academy of Sciences 105 (29), 9953-9958, 2008
1932008
Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism
K Xu, Z Wu, N Renier, A Antipenko, D Tzvetkova-Robev, Y Xu, ...
Science 344 (6189), 1275-1279, 2014
1882014
Quantification of the impact of the HIV-1-glycan shield on antibody elicitation
T Zhou, NA Doria-Rose, C Cheng, GBE Stewart-Jones, GY Chuang, ...
Cell reports 19 (4), 719-732, 2017
1792017
Enhanced neutralization resistance of SARS-CoV-2 omicron subvariants BQ. 1, BQ. 1.1, BA. 4.6, BF. 7, and BA. 2.75. 2
P Qu, JP Evans, JN Faraone, YM Zheng, C Carlin, M Anghelina, ...
Cell host & microbe 31 (1), 9-17. e3, 2023
1642023
Nanobodies from camelid mice and llamas neutralize SARS-CoV-2 variants
J Xu, K Xu, S Jung, A Conte, J Lieberman, F Muecksch, JCC Lorenzi, ...
Nature 595 (7866), 278-282, 2021
1622021
A treatment for and vaccine against the deadly Hendra and Nipah viruses
CC Broder, K Xu, DB Nikolov, Z Zhu, DS Dimitrov, D Middleton, J Pallister, ...
Antiviral research 100 (1), 8-13, 2013
1542013
Eph/ephrin recognition and the role of Eph/ephrin clusters in signaling initiation
DB Nikolov, K Xu, JP Himanen
Biochimica et Biophysica Acta (BBA)-Proteins and Proteomics 1834 (10), 2160-2165, 2013
1352013
Neutralization of SARS-CoV-2 Omicron sub-lineages BA. 1, BA. 1.1, and BA. 2
JP Evans, C Zeng, P Qu, J Faraone, YM Zheng, C Carlin, JS Bednash, ...
Cell host & microbe 30 (8), 1093-1102. e3, 2022
1142022
Antibody lineages with vaccine-induced antigen-binding hotspots develop broad HIV neutralization
R Kong, H Duan, Z Sheng, K Xu, P Acharya, X Chen, C Cheng, ...
Cell 178 (3), 567-584. e19, 2019
1042019
Vaccine induction of heterologous tier 2 HIV-1 neutralizing antibodies in animal models
KO Saunders, LK Verkoczy, C Jiang, J Zhang, R Parks, H Chen, ...
Cell reports 21 (13), 3681-3690, 2017
1012017
Structure-based design of a soluble prefusion-closed HIV-1 Env trimer with reduced CD4 affinity and improved immunogenicity
GY Chuang, H Geng, M Pancera, K Xu, C Cheng, P Acharya, ...
Journal of virology 91 (10), 10.1128/jvi. 02268-16, 2017
902017
Neutralization and stability of SARS-CoV-2 Omicron variant
C Zeng, JP Evans, P Qu, J Faraone, YM Zheng, C Carlin, JS Bednash, ...
biorxiv, 2021
882021
Insights into Eph receptor tyrosine kinase activation from crystal structures of the EphA4 ectodomain and its complex with ephrin-A5
K Xu, D Tzvetkova-Robev, Y Xu, Y Goldgur, YP Chan, JP Himanen, ...
Proceedings of the National Academy of Sciences 110 (36), 14634-14639, 2013
822013
SARA, a FYVE domain protein, affects Rab5-mediated endocytosis
Y Hu, JZ Chuang, K Xu, TG McGraw, CH Sung
Journal of cell science 115 (24), 4755-4763, 2002
792002
Crystal structure of the pre-fusion Nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly
K Xu, YP Chan, B Bradel-Tretheway, Z Akyol-Ataman, Y Zhu, S Dutta, ...
PLoS pathogens 11 (12), e1005322, 2015
762015
Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4
GBE Stewart-Jones, GY Chuang, K Xu, T Zhou, P Acharya, Y Tsybovsky, ...
Proceedings of the National Academy of Sciences 115 (48), 12265-12270, 2018
712018
The system can't perform the operation now. Try again later.
Articles 1–20